statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	828
IT - Italia	416
RU - Federazione Russa	317
CN - Cina	123
SG - Singapore	119
IE - Irlanda	116
DE - Germania	78
BR - Brasile	77
HK - Hong Kong	57
FI - Finlandia	37
NL - Olanda	35
FR - Francia	34
GB - Regno Unito	33
KR - Corea	32
AU - Australia	29
SE - Svezia	26
CA - Canada	24
IN - India	24
VN - Vietnam	23
JP - Giappone	17
ES - Italia	14
KZ - Kazakistan	14
CZ - Repubblica Ceca	13
CH - Svizzera	12
AT - Austria	11
AR - Argentina	9
TW - Taiwan	9
CI - Costa d'Avorio	8
PL - Polonia	7
TR - Turchia	6
BD - Bangladesh	5
IQ - Iraq	5
IR - Iran	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
IL - Israele	3
PK - Pakistan	3
UA - Ucraina	3
CL - Cile	2
LT - Lituania	2
LV - Lettonia	2
MX - Messico	2
TT - Trinidad e Tobago	2
AZ - Azerbaigian	1
BH - Bahrain	1
BY - Bielorussia	1
CY - Cipro	1
DK - Danimarca	1
EC - Ecuador	1
GE - Georgia	1
GT - Guatemala	1
HN - Honduras	1
LK - Sri Lanka	1
ML - Mali	1
MY - Malesia	1
NO - Norvegia	1
PE - Perù	1
PT - Portogallo	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TL - Timor Orientale	1
VE - Venezuela	1
Totale	2.611

Nome	#
A first update on mapping the human genetic architecture of COVID-19	539
Approaching PCDH19 clustering epilepsy in vitro: CRISPR/Cas9-mediated gene editing and characterization of patient-derived hiPSC-neurons	380
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males	328
Mapping the human genetic architecture of COVID-19	262
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients	232
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes	197
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age	191
Whole-genome sequencing reveals host factors underlying critical COVID-19	143
SELP Asp603Asn and severe thrombosis in COVID-19 males	140
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells	128
Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males	122
Totale	2.662

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	90	10	6	0	6	1	0	4	4	6	6	13	34
2022/2023	318	8	13	13	31	20	45	42	25	36	30	34	21
2023/2024	411	35	22	30	19	33	70	70	40	6	24	34	28
2024/2025	686	35	36	80	39	78	61	56	52	50	40	65	94
2025/2026	1.157	88	247	314	202	291	15	0	0	0	0	0	0
Totale													2.662